MACOPHARMA: public contracts won without a rival in France: 2 uncontested awards; 25% of its awards; 2 without a competition; 0 single bid.
Assay record ASY-FR-151W2MG0H3 · Cite as: Assay Systems, “MACOPHARMA: public contracts won without a rival in France”, https://assay-systems.com/register/fr/uncontested/s/macopharma/
MACOPHARMA won 2 of its 8 public contract awards in France without a rival from 2024-02-19 to 2026-03-11: 2 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest CHU MONTEPLLIER with 1.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
CHU MONTEPLLIER gave MACOPHARMA 1 award: 1 without a competition, 0 after a competition with a single bid. First 2024-03-05, latest 2024-03-05.
Etablissement français du sang gave MACOPHARMA 4 awards: 1 without a competition, 0 after a competition with a single bid. First 2024-02-19, latest 2026-03-11.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2026-03-11 | Etablissement français du sang 170628-2026 | No competition neg-wo-call | other-exclusive |
| 2024-03-05 | CHU MONTEPLLIER 133930-2024 | No competition neg-wo-call | exclusive |
Every uncontested award in France · All countries · MACOPHARMA in the register
Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.